Skip to main content
. 2022 Aug 25;14(9):1771. doi: 10.3390/pharmaceutics14091771

Table 4.

Hematological indicators in the female Wistar rats treated for 14 days with saline, blank NLCs, NRG NLCs, RLX NLCs, and RLX/NRG NLCs (mean ± SD, n = 6).

Parameters (Unit) Control Blank NLCs NRG NLCs RLX NLCs RLX/NRG NLCs
Hemoglobin (gm/dl) 14.3 ± 1.02 15.8 ± 0.68 12.7 ± 0.5 13.9 ± 0.62 12.2 ± 0.8
TLC (total leucocyte count) (th/cumm) 8.5 ± 0.2 8.4 ± 0.3 7.8 ± 0.2 4.4 ± 1.2 7.6 ± 1.01
Polymorphs (%) 50 ± 3.2 60 ± 2.2 39 ± 1.5 40 ± 1.7 32 ± 2.4
Lymphocytes (%) 45 ± 4.3 35 ± 3.2 52 ± 1.8 52 ± 0.5 61 ± 1.2
Eosinophil (%) 02 ± 0.3 02 ± 0.1 06 ± 0.2 05 ± 0.1 03 ± 0.3
Monocytes (%) 03 ± 0.2 03 ± 0.2 03 ± 0.02 03 ± 0.01 04 ± 0.1
RBC (millions/cumm) 7.3 ± 0.87 6.58 ± 2.3 6.7 ± 1.8 7.9 ± 1.5 6.8 ± 0.6
HCT (%) 50.3 ± 5.3 39.5 ± 2.5 45.6 ± 1.7 47.8 ± 2.1 43.2 ± 1.1
MCV (fl) 68.6 ± 3.3 80.6 ± 3.1 68.1 ± 1.5 60.6 ± 1.1 63.4 ± 0.8
MCH (pg) 19.5 ± 1.2 26.5 ± 2.2 18.9 ± 1.2 17.6 ± 1.4 17.8 ± 0.56
MCHC (g/dl) 28.5 ± 2.1 30.5 ± 1.1 27.7 ± 2.01 29 ± 0.5 28.1 ± 1.05
Platelet count (th/µL) 874 ± 5.3 652 ± 4.3 745 ± 3.2 847 ± 5.3 840 ± 6.31
MPV (fl) 7.1 ± 0.4 8.5 ± 1.1 7.2 ± 0.5 7.6 ± 1.2 8.9 ± 0.5
RDW-CV (%) 15.9 ± 1.2 14.5 ± 1.3 14.8 ± 0.5 16 ± 1.02 13.8 ± 0.7
RDW-SD (fl) 55.8 ± 2.5 45.6 ± 1.2 47.8 ± 2.1 41.5 ± 1.3 47.8 ± 2.2
PCT (%) 0.7 ± 0.2 0.6 ± 0.3 0.7 ± 0.1 0.6 ± 0.2 0.8 ± 0.2
PDW-SD (fl) 15.4 ± 0.3 15.6 ± 0.5 15.4 ± 0.2 15.2 ± 0.1 15.9 ± 0.3